0A7V Stock Overview
Engages in the production and sale of biochemicals in Australia, France, the United Kingdom, Belgium, and Norway.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Circa Group AS Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 5.54 |
| 52 Week High | NOK 6.39 |
| 52 Week Low | NOK 5.54 |
| Beta | 0.36 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -66.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0A7V | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0% | 4.1% | 0.8% |
| 1Y | n/a | -27.3% | 10.9% |
Return vs Industry: Insufficient data to determine how 0A7V performed against the UK Chemicals industry.
Return vs Market: Insufficient data to determine how 0A7V performed against the UK Market.
Price Volatility
| 0A7V volatility | |
|---|---|
| 0A7V Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 7.4% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0A7V has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0A7V's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 18 | Tony Duncan | www.circa-group.com |
Circa Group AS engages in producing bio-based chemicals in Australia, France, the United Kingdom, Belgium, and Norway. The company extracts value from non-food waste biomass to produce bio-based chemicals through its proprietary Furacell process. Its products include Cyrene, a polar aprotic solvent; and Levoglucosenone derivatives.
Circa Group AS Fundamentals Summary
| 0A7V fundamental statistics | |
|---|---|
| Market cap | NOK 467.63m |
| Earnings (TTM) | -NOK 64.28m |
| Revenue (TTM) | NOK 19.12m |
24.5x
P/S Ratio-7.3x
P/E RatioIs 0A7V overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0A7V income statement (TTM) | |
|---|---|
| Revenue | €1.65m |
| Cost of Revenue | €539.63k |
| Gross Profit | €1.11m |
| Other Expenses | €6.66m |
| Earnings | -€5.55m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Nov 09, 2023
| Earnings per share (EPS) | -0.046 |
| Gross Margin | 67.33% |
| Net Profit Margin | -336.21% |
| Debt/Equity Ratio | 0% |
How did 0A7V perform over the long term?
See historical performance and comparison